Keyphrases
Osteoporosis
100%
Adherence to Screening
100%
Risk Assessment
100%
Breast Cancer Survivors
100%
Screening Recommendations
100%
Hormone Therapy
100%
Aromatase Inhibitors
75%
Confidence Interval
50%
Hazard Ratio
25%
Breast Cancer
25%
Bone Mineral Density
25%
Everyday Practices
25%
Off-treatment
25%
Cox Proportional Hazards Model
12%
Adjusted Hazard Ratio
12%
Effective Strategies
12%
Age-related
12%
Multivariable
12%
Breast Cancer Patients
12%
Invasive Breast Cancer
12%
Healthcare
12%
Cumulative Incidence
12%
Subgroup Analysis
12%
Protective Effect
12%
Case-cohort Study
12%
Female Breast Cancer
12%
Competing Risks
12%
Menopausal Status
12%
Patient Risk
12%
Monotherapy
12%
Induced Risk
12%
Postmenopausal Women
12%
Inhibitor Treatment
12%
Sequential Treatment
12%
Bone Health
12%
Postmenopausal Patients
12%
Screening Adherence
12%
Medicine and Dentistry
Breast Cancer
100%
Osteoporosis
100%
Hormone Therapy
100%
Aromatase Inhibitor
75%
Hazard Ratio
37%
Bone Density
25%
Tamoxifen
25%
Proportional Hazards Model
12%
Cohort Analysis
12%
Cumulative Incidence
12%
Subgroup Analysis
12%
Monotherapy
12%
Postmenopause
12%
Nursing and Health Professions
Breast Cancer
100%
Hormonal Therapy
100%
Aromatase Inhibitor
85%
Confidence Interval
57%
Hazard Ratio
42%
Tamoxifen
28%
Bone Density
28%
Cohort Analysis
14%
Proportional Hazards Model
14%
Monotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Endocrine Therapy
100%
Aromatase Inhibitor
85%
Tamoxifen
28%
Cohort Study
14%
Monotherapy
14%